Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Infectious Disease Reports
Erschienen in: Current Infectious Disease Reports 5/2011

01.10.2011

Recent Advances in the Treatment of Necrotizing Fasciitis

verfasst von: Marina S. Morgan

Erschienen in: Current Infectious Disease Reports | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

With four types of necrotizing fasciitis (NF) now recognized, the diagnosis and management of NF becomes more challenging as physicians face more unusual pathogenic and atypical presentations. With few published guidelines and little evidence base to justify therapies, much of the literature is pragmatic or provides limited evidence with small underpowered studies and disparate case reports.
Literatur
1.
Meleney FL. Haemolytic streptococcal gangrene. Importance of early diagnosis and early operation. JAMA. 1929;92:2009–12.
2.
Fournier J-A. Gangrène foudroyante de la verge. La Semaine Medicale. 1883;3:345–8.
3.
Giuliano A, Lewis Jr F, Hadley K, et al. Bacteriology of necrotizing fasciitis. Am J Surg. 1977;134:52–7.PubMedCrossRef
4.
•• Morgan MS. Diagnosis and management of necrotising fasciitis: a multiparametric approach. J Hosp Infect. 2010;75:249–57. The most recent overview, and a new classification of necrotizing fasciitis. PubMedCrossRef
5.
Nuwayhid ZB, Aronoff DM, Mulla ZD. Blunt trauma as a risk factor for group A streptococcal necrotizing fasciitis. Ann Epidemiol. 2007;17:878–81.PubMedCrossRef
6.
Yamashiro E, Asato Y, Taira K, et al. Necrotizing fasciitis caused by Streptococcus pneumoniae. J Dermatol. 2009;36:298–305.PubMedCrossRef
7.
Lee YT, Chou TD, Peng MY, et al. Rapidly progressive necrotizing fasciitis caused by Staphylococcus aureus. J Microbiol Immunol Infect. 2005;38:361–4.PubMed
8.
Regev A, Weinberger M, Fishman M, et al. Necrotizing fasciitis caused by Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 1998;17:101–3.PubMed
9.
Romano R, Lu D, Holtom P. Outbreak of community-acquired methicillin-resistant Staphylococcus aureus skin infections among a collegiate football team. J Athl Train. 2006;41:141–5.PubMed
10.
Alvarez CA, Barientes OJ, Leal AL, et al. Community-associated Methicillin-resistant Staphylococcus aureus, Colombia. Emerg Infect Dis. 2006;12:2001–2.
11.
Lee TC, Carrick M, Scott BG, et al. The incidence and clinical characteristics of methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a large urban hospital American. J Surg. 2007;194:809–13.CrossRef
12.
Wong CH, Tan SH, Kurup A, et al. Recurrent necrotizing fasciitis caused by methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 2004;23:909–11.PubMed
13.
Bodemer C, Panhans A, Chretien-Marquet B, et al. Staphylococcal necrotizing fasciitis in the mammary region in childhood: a report of five cases. J Pediatr. 1997;131:466–9.PubMedCrossRef
14.
Peker E, Kirimi E, Tuncer O, et al. Necrotizing fasciitis caused by Staphylococcus epidermidis in a neonate with extremely low birthweight. J Dermatol. 2010;37:671–3.PubMedCrossRef
15.
Carmin M, Kalorin CM, Tobin EH. Community associated methicillin resistant Staphylococcus Aureus causing Fournier’s gangrene and genital infections. 2007;177:967–71.
16.
Young LM, Price CS. Community-acquired methicillin-resistant Staphylococcus aureus emerging as an important cause of necrotizing fasciitis. Surg Infect. 2008;9:469–74.CrossRef
17.
Ohlsen RJ, Burns KM, Chen L, et al. Severe necrotizing fasciitis in a human immunodeficiency virus-positive patient caused by methicillin-resistant Staphylococcus aureus. J Clin Micro. 2008;46:1144–7.CrossRef
18.
Dehority W, Wang E, Vernon PS, et al. Community-associated methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a neonate. Pediatr Infect Dis J. 2006;25:1080–1.PubMedCrossRef
19.
Hayani KC, Mathew R, Oyedele T, Hulten KG. Neonatal necrotizing fasciitis due to community-acquired methicillin resistant Staphylococcus aureus. Pediatr Infect Dis J. 2008;27:480–81.PubMedCrossRef
20.
Orii KO, Iwao Y, Higuchi W, et al. Molecular characterization of methicillin resistant Staphylococcus aureus from a fatal case of necrotizing fasciitis in an extremely low-birth-weight infant. Clin Microbiol Infect. 2010;16:289–92.PubMedCrossRef
21.
Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med. 2005;352:1445–53.PubMedCrossRef
22.
• Salcido R: Necrotizing fasciitis: reviewing the causes and treatment strategies. Adv Skin Wound Care 2007; 20:288–93. Excellent overview- covers most aspects of diagnosis and therapy. PubMedCrossRef
23.
•• Sarani B, Strong M, Pascual J et al. Necrotizing fasciitis: current concepts and review of the literature. J Am Coll Surg. 2009;208:279–88. Very comprehensive and thorough overview. Excellent photographs and tables, and easy to read. PubMedCrossRef
24.
Goodell KH, Jordan MR, Graham R, et al. Rapidly advancing necrotizing fasciitis caused by Photobacterium (Vibrio) damsela: a hyperaggressive variant. Crit Care Med. 2004;32:278–81.PubMedCrossRef
25.
Lee C-H, Wang C-C, Yue C-T Li J-Y WuY-K. Necrotising fasciitis caused by Vibrio vulnificus in a man with cirrhosis. Lancet Infect Dis. 2008;8:399.PubMedCrossRef
26.
Klontz KC, Lieb S, Schreiber M, et al. Syndromes of Vibrio vulnificus infections. Clinical and epidemiological features in Florida cases, 1981–1987. Ann Intern Med. 1988;109:318.PubMed
27.
28.
McLellan E, Suvarna K, Townsend R. Fatal necrotising fasciitis caused by Haemophilus influenzae serotype f. J Med Microbiol. 2008;57:249–51.PubMedCrossRef
29.
Saito T, Matsunaga H, Matsumura Y, et al. Necrotizing fasciitis caused by Haemophilus influenzae type b in an elderly patient. J Clin Microbiol. 2009;47:852–4.PubMedCrossRef
30.
Wong CH, Kurup A, Wang YS, et al. Four cases of necrotizing fasciitis caused by Klebsiella species. Eur J Clin Microbiol Infect Dis. 2004;23:403–7.PubMedCrossRef
31.
Monaghan SF, Anjaria D, Mohr A, et al. Necrotizing fasciitis and sepsis caused by Aeromonas hydrophila after crush injury of the lower extremity. Surg Infect. 2008;9:459–67.CrossRef
32.
Cui H, Hao S, Arous E. A distinct cause of necrotizing fasciitis: Aeromonas veronii Biovar Sobria. Surg Infect. 2007;8:523–8.CrossRef
33.
• Charnot-Katsikas A, Dorafshar AH, Aycock JK et al. Two cases of necrotizing fasciitis due to Acinetobacter baumannii. J Clin Microbiol. 2009;47:258–63. Worrying cases of multi-drug resistant NF superinfection in immunocompromised patient.
34.
Cook DA, Heiner JP, Rao VK. Necrotizing candidal fasciitis following hip surgery. Orthopedics. 1990;13:768–70.PubMed
35.
Shindo M, Yoshida Y, Adachi K, et al. Necrotizing soft-tissue infection caused by both Candida glabrata and Streptococcus agalactiae. Arch Dermatol. 2009;145:I96–97.CrossRef
36.
Jain D, Kumar Y, Vasishta RK, et al. Zygomycotic necrotizing fasciitis in immunocompetent patients: a series of 18 cases. Mod Pathol. 2006;19:1221–6.PubMedCrossRef
37.
Aronoff DM, Bloch KC. Assessing the relationship between the use of NSAIDS and necrotizing fasciitis caused by group A streptococcus. Medicine. 2003;82:225–35.PubMed
38.
Wong CH, Khin LW, Heng KS. The laboratory risk indicator for necrotising fasciitis score: a tool for distinguishing necrotising fasciitis from other soft tissue infection. Crit Care Med. 2004;32:135–41.CrossRef
39.
Su Y-C, Chen H-W, Hong Y-C, et al. Laboratory risk indicator for necrotizing fasciitis and the outcomes. ANZJ Surg. 2008;78:968–72.CrossRef
40.
Macuha F, Ahn A, Graham R. Necrotizing fasciitis associated with acupuncture: a case report. J Hosp Med. 2010;10:565–6.CrossRef
41.
Barie PS. The laboratory risk indicator for necrotizing fasciitis (LRINEC) score: useful tool or paralysis by analysis? Crit Care Med. 2004;32:1618–9.PubMedCrossRef
42.
Wang T-W, Hung C-R. Role of tissue oxygen saturation monitoring in diagnosing necrotizing fasciitis of the lower limbs. Ann Emerg Med. 2004;44:222–8.PubMedCrossRef
43.
Zahar J-R Goveia J, Lesprit P, et al. Severe soft tissue infections of the extremities in patients admitted to an intensive care unit. CMI. 2004;11:79–82.
44.
Darbar A, Harris IA, Gosbell IB. Necrotizing infection due to Bacillus cereus mimicking gas gangrene following penetrating trauma. J Orthop Trauma. 2005;19:353–5.PubMed
45.
• Sada A, Misago N, Okawa T, et al. Necrotizing fasciitis and myonecrosis “synergistic necrotizing cellulitis” caused by Bacillus cereus J Dermatol. 2009;36:423–26. Case report with good X-rays and photographs of an infection that could easily be mistreated. PubMedCrossRef
46.
Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the management of skin and soft tissue infections. Clin Infect Dis. 2005;41:1373–406.PubMedCrossRef
47.
48.
Tang WM, Ho PL, Fung KK, et al. Necrotizing fasciitis of a limb. J Bone Joint Surg [Br]. 2001;83-B:709–14.CrossRef
49.
• Lehnhardt M, Homann H, Daigeler A, et al. Major and lethal complications of liposuction: a review of 72 cases in Germany between 1998 and 2002. Plast Reconstr Surg. 2008;121:396e–403e. Surgically orientated but very useful background for understanding of infections following plastic surgery procedures. PubMedCrossRef
50.
Andreasson TJ, Green SD, Childers BJ. Massive soft tissue injury: diagnosis and management of necrotising fasciitis and purpura fulminans. Plast Reconstr Surg. 2001;107:1025–34.CrossRef
51.
Eagle H. Experimental approach to the problem of treatment failures with penicillin. I. Group A streptococcal infection in mice. Am J Med. 1952;13:389–99.PubMedCrossRef
52.
Stevens DL, Gibbons AE, Bergstrom R, et al. The Eagle effect revisited: efficacy of clindamycin, erythromycin and penicillin in the treatment of streptococcal myositis. J Infect Dis. 1988;158:23–8.PubMedCrossRef
53.
De Decker K, Van Poucke S, Wojciechowski M, et al. Successful use of posaconazole in a pediatric case of fungal necrotizing fasciitis. Pediatr Crit Care Med. 2006;7:482–5.PubMedCrossRef
54.
Stevens DL, Ma Y, McIndoo E, et al. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis. 2007;195:202–11.PubMedCrossRef
55.
Bakleh M, Wold LE, Mandrekar JN, et al. Correlation of histopathological findings with clinical outcome in necrotizing fasciitis. Clin Infect Dis. 2005;40:410–4.PubMedCrossRef
56.
Mulla ZD, Leaverton PE, Wiersma ST. Invasive group A streptococcal infections in Florida. South Med J. 2003;968–73.
57.
Zimbelman J, Palmer A, Todd J. Improved outcome of clindamycin compared with beta-lactam antibiotics treatment for invasive Streptococcus pyogenes infection. Paed Inf Dis J. 1999;12:1096–110.CrossRef
58.
Panagaea S, Perry JD, Gould JK. Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant streptococci? J Antimicrob Chemother. 1999;44:581–2.CrossRef
59.
Diener BC. Avoidance of dominant hand amputation in a patient with uncontrolled diabetes. Adv Skin Wound Care. 2010;23:219–22.PubMedCrossRef
60.
Lamothe F, D’Amico P, Ghosn P, et al. Clinical usefulness of human immunoglobulins in invasive group A streptococcus infections: a review. Clin Infect Dis. 1995;21:469–70.CrossRef
61.
Korzets A, Ori Y, Zevin D, et al. Streptococcal bacteraemia and necrotizing fasciitis in a renal transplant patient; a case for intravenous immunoglobulin therapy. Nephrol Dial Transplant. 2002;17:150–2.PubMedCrossRef
62.
Yaghoubian A, de Virgilio C, Dauphine C, et al. Use of admission serum lactate and sodium levels to predict mortality in necrotizing soft tissue infection. Arch Surg. 2007;142:840–6.PubMedCrossRef
63.
Cawley MJ, Briggs M, Haith LR, et al. Intravenous immunoglobulin as adjunctive treatment for Streptococcal toxic shock syndrome associated with necrotizing fasciitis: case report and review. Pharmacotherapy. 1999;19:1094–98.PubMedCrossRef
64.
•• de Moya MA, del Carmen MG, Allain RM et al. Case 33–2009: a 35-year-old woman with fever, abdominal pain, and hypotension after cesarean section. N Engl J Med. 2009;361:1689–97. An instructive case of GASNF following caesarian and the complications and management problems. Good histological and clinical photographs. PubMedCrossRef
65.
Kaul R, McGreer A, Low DE, et al. Population based surveillance for Group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of 77 cases. Am J Med. 1997;103:18–24.PubMedCrossRef
66.
Mehta S, McGeer A, Low DE, et al. Morbidity and mortality of patients with invasive group A streptococcal infections admitted to the ICU. Chest. 2006;130:1679–86.PubMedCrossRef
67.
Alejandria MM, Lansang MAD, Dans LF, et al. Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. Cochrane Database Syst Rev. 2002; Issue 1. Art. No.: CD001090. doi:10.​1002/​14651858.​CD001090.
68.
Minodier P, Bidet P, Rallu F, et al. Clinical and microbiologic characteristics of group A streptococcal necrotising fasciitis in children. Ped Infect Dis J. 2009;28:541.CrossRef
69.
Darenberg J, Ihendyane N, Sjölin J, et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2003;37:333–40.PubMedCrossRef
70.
Chapman SJR, Opdam H, Donato R, et al. Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous immunoglobulin together with a conservative surgical approach. Scand J Infect Dis. 2006;38:742–3.PubMedCrossRef
71.
72.
Sellers BJ, Woods ML, Morris ASE, et al. Necrotizing Group A streptococcal infection associated with streptococcal toxic shock syndrome. Am J Surg. 1996;172:523–8.PubMedCrossRef
73.
Meredith FT, Fowler VG, Gautier M, et al. Bacillus cereus necrotizing cellulitis mimicking clostridial myonecrosis: case report and review of the literature. Scand J Infect. 1997;29:528–9.CrossRef
74.
Bilton BB, Zibarui GB, McMillan RW, et al. Aggressive surgical management of necrotising fasciitis serves to decrease mortality: a retrospective study. Amer Surg. 1998;64:397–401.
75.
Wakhlu A, Chaudhary A, Tandon RK, et al. Conservative management of necrotizing fasciitis in children. J Pediatr Surg. 2006;41:1144–8.PubMedCrossRef
76.
Bingöl-Kologlu M, Yildiz RV, Alper B, et al. Necrotizing fasciitis in children: diagnostic and therapeutic aspects. J Pediatr Surg. 2007;42:1892–7.PubMedCrossRef
77.
Wong C-H, Yam AK-T, Tan A, et al. Approach to debridement in necrotizing fasciitis. Am J Surg. 2008;196:e19–24. A thorough surgical paper especially useful for microbiologists who are not regularly in theatre.PubMedCrossRef
78.
Tahmaz L, Eedemir T, Kibar Y, et al. Fournier’s gangrene: report of thirty-three cases and a review of the literature. Int J Urol. 2006;13:960–7.PubMedCrossRef
79.
Minhas KM. Pneumococcal purpura fulminans successfully treated with activated Protein C. [Report]. South Med J. 2008;101:1046–8.PubMedCrossRef
80.
81.
Nagoba BS, Gandhi RC, Wadher BJ, et al. Citric acid treatment of necrotizing fasciitis: a report of two cases. Int Wound J. 2010;7:536–8.PubMedCrossRef
82.
Nagoba BS, Gandhi RC, Wadher BJ, et al. Microbiological, histopathological and clinical changes in chronic wounds after citric acid treatment. J Med Microbiol. 2008;57:681–2.PubMedCrossRef
83.
• Sakata S, Das Gupta R, Leditschke JF et al. Extensive necrotising fasciitis in a 4-day-old neonate: a successful outcome from modern dressings, intensive care and early surgical intervention. Pediatr Surg Int. 2009;25:117–9.PubMedCrossRef
84.
Fitzgerald RH, Bharara M, Mills JL, et al. Use of a Nanoflex powder dressing for wound management following debridement for necrotising fasciitis in the diabetic foot. Int Wound J. 2009;6:133–9.PubMedCrossRef
85.
•• Czymek, R, Schmidt A, Eckmann C et al. Fournier’s gangrene: vacuum-assisted closure versus conventional dressings. Am J Surg. 2009;197:168–76. Case series and excellent overview of history of FG, VAC device and surgery. Good photographs. PubMedCrossRef
86.
Gorlek A, Firat C, Oztqrk AE, et al. Management of necrotizing fasciitis in diabetic patients. J Diabet Comp. 2007;21:265–71.CrossRef
87.
Jallali N, Ithey S, Butler PE. Hyperbaric oxygen as adjuvant therapy in the management of necrotizing fasciitis. Am J Surg. 2005;189:462–6. Thorough and honest overview explaining mechanisms of HBO action, pros and cons of HBO and review of cases where HBO used.PubMedCrossRef
88.
Kakis A, Gibbs L, Equia J, et al. An outbreak of Group A streptococcal infection among health care workers. Clinic Inf Dis. 2002;35:1353–9.CrossRef
89.
• Sablier F, Slaouti T, Drèze P-A et al. Nosocomial transmission of necrotising fasciitis. Lancet. 2010;375:1052. Transmission after blade injury during surgery. PubMedCrossRef
90.
Gamba M-A, Martinelli M, Schaad HJ, et al. Familial transmission of a serious disease –producing Group A streptococcus clone: case reports and review. Clin Infect Dis. 1997;24:1118–21.PubMedCrossRef
91.
Interim UK guidelines for management of close community contacts of invasive group A streptococcal disease. Comm Dis Pub Health. 2004;7:364–71.
92.
Wong C-H, Song C, Ong Y-S et al. Abdominal wall necrotizing fasciitis: it is Still “Meleney’s minefield”. Plastic Reconstruct Surg. 2006;147–150e.
Metadaten
Titel
Recent Advances in the Treatment of Necrotizing Fasciitis
verfasst von
Marina S. Morgan
Publikationsdatum
01.10.2011
Verlag
Current Science Inc.
Erschienen in
Current Infectious Disease Reports / Ausgabe 5/2011
Print ISSN: 1523-3847
Elektronische ISSN: 1534-3146
DOI
https://doi.org/10.1007/s11908-011-0205-9

Weitere Artikel der Ausgabe 5/2011

Current Infectious Disease Reports 5/2011 Zur Ausgabe

ReviewPaper

Community-Acquired Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections: Management and Prevention

ReviewPaper

Soft Tissue Infections Caused by Marine Bacterial Pathogens: Epidemiology, Diagnosis, and Management

ReviewPaper

Antibiotic Therapy in Neonatal and Pediatric Septic Shock

ReviewPaper

What’s New in the Management of Bacterial Septic Arthritis?

ReviewPaper

When and How to Cover for Resistant Gram-Negative Bacilli in Severe Sepsis and Septic Shock

ReviewPaper

Advances in the Diagnosis and Management of Pediatric Osteomyelitis

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise